Literature DB >> 4290149

Metabolism of tritiated vitamin D3 in familial vitamin D-resistant rickets with hypophosphatemia.

H F DeLuca, J Lund, A Rosenbloom, C C Lobeck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4290149     DOI: 10.1016/s0022-3476(67)80342-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

1.  Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3.

Authors:  J W Blunt; Y Tanaka; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1968-12       Impact factor: 11.205

2.  The biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3.

Authors:  J W Blunt; Y Tanaka; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

3.  Pathogenesis of rickets and osteomalacia in familial hypophosphataemia.

Authors:  J R Condon; J R Nassim; A Rutter
Journal:  Arch Dis Child       Date:  1971-06       Impact factor: 3.791

Review 4.  Metabolic bone disease secondary to renal and intestinal disorders.

Authors:  F P Muldowney
Journal:  Calif Med       Date:  1969-05

5.  Metabolites of vitamin D in normal and X-linked hypophosphatemic mice.

Authors:  R A Meyer; M H Meyer; R W Gray
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

6.  Metabolism of vitamin D3-3H in vitamin D-resistant rickets and familial hypophosphatemia.

Authors:  L V Avioli; T F Williams; J Lund; H F DeLuca
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

7.  25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.

Authors:  S Balsan; M Garabedian
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.